Effect of acupuncture on insomnia in menopausal women: A study protocol for a randomized controlled trial
PublisherBioMed Central Ltd.
MetadataShow full item record
AbstractBackground: The National Institutes of Health estimates the prevalence of insomnia in menopausal women at 40-50%. Some studies have shown that acupuncture might be effective in treating primary insomnia and insomnia related to depression and stroke. Although there are some programs supporting insomnia during the menopausal transition, there are few randomized controlled trials (RCT) to provide evidence regarding their effectiveness. We design a RCT of suitable sample size to verify the effectiveness of acupuncture in patients with insomnia during the menopausal transition and to form an optimized acupuncture treatment protocol. Method/Design: In this randomized, single-site, single-blind, placebo-controlled trial, 84 eligible patients will be recruited and randomly assigned to either the acupuncture group (n = 42) or the sham control group (n = 42) in a 1:1 ratio. Participants will receive a total of 18 treatment sessions for eight consecutive weeks. Treatments will be given three times per week in the first four weeks, twice a week for the next two weeks, and finally once weekly for the final two weeks. Treatment will utilize eight main acupoints (GV20, GV24, GV29, RN6, RN4, SP6, HT7, EX-HN22) and extra two acupoints based on syndrome differentiation. The primary outcome will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The secondary outcomes will be measured by sleep parameters recorded in the Actigraphy (SE, TST, SA), Insomnia Severity Index (ISI), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and Menopause Quality of Life (Men-QOL). The primary outcomes will be assessed at baseline, week 4, week 8, and the first and third month after the end of treatment. Discussion: If the results confirm that acupuncture is effective and safe for the treatment on insomnia in menopausal women, this positive outcome could provide evidence for clinical application. Trial registration: Chinese Clinical Trial Registry, ChiCTR1800018645. Registered on 10 January 2018. Copyright 2019 The Author(s).
SponsorsThe study is partly supported by grants from Shanghai Committee of Science and Technology, China (No. 18401905200). Shanghai Hospital Development Center, China (No. SHDC12016124), Shanghai Municipal Commission of Health and Family Planning, China (No. 201640026) and State Administration of Traditional Chinese Medicine, China (Grant No. JDZX2015024).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85066611239&doi=10.1186%2fs13063-019-3374-8&partnerID=40&md5=0c0900ab08bcf64207a542ab8cd5cc6d; http://hdl.handle.net/10713/10610